Eculizumab in STEC-HUS with severe neurological involvement: a New Zealand perspective
Crossref DOI link: https://doi.org/10.1007/s00467-023-06226-z
Published Online: 2023-11-30
Published Print: 2024-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Selvathesan, Nithiakishna https://orcid.org/0000-0001-7780-9260
Wong, William
Prestidge, Chanel
Text and Data Mining valid from 2023-11-30
Version of Record valid from 2023-11-30
Article History
Received: 17 October 2023
Revised: 18 October 2023
Accepted: 19 October 2023
First Online: 30 November 2023
Declarations
:
: The authors declare no competing interests.